ReviewCancer biology & medicine2025
Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications.
Review in Cancer biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Single-cell transcriptomics and functional validation reveal a TUBB4B-associated malignant epithelial state in nasopharyngeal carcinoma.Journal of translational medicine · 2026Article
- Primary cilia connect epithelial mesenchymal plasticity with anoikis resistance and cancer stemness.Discover oncology · 2026Review
- Harnessing cutting-edge techniques to identify novel gene expression signatures in acute myeloid leukemia patients.Frontiers in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Primary cilia, microtubule-based organelles protruding from the surfaces of most eukaryotic cells, have critical roles in maintaining cellular homeostasis, by sensing, transducing, and transmitting diverse extracellular and intracellular signals through multiple signaling pathways, including the Hedgehog, Notch, and Wnt pathways. Consequently, structural or functional abnormalities in primary cilia often lead to various human diseases, including cancer. Although primary cilia are frequently absent in most cancer types, they paradoxically facilitate tumor initiation and progression in certain malignancies. Therefore, elucidating the complex interplay between primary cilia and cancer might provide novel insights for cancer treatment. In this review, we summarize current insights into the structure and function of primary cilia, explore their roles in key tumor-associated signaling pathways, and discuss emerging evidence linking ciliary dysfunction to cancer development and progression. We also highlight recent advances in targeting cilia-associated mechanisms as potential therapeutic strategies in oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.